Sepsis under siege: a new understanding of sepsis might lead to the development of therapies to treat septic shock.
Hunter
Philip
P
D024243:HMGB1 Protein / Q000502:physiology; D006801:Humans; D018448:Models, Immunological; D011486:Protein C / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D018805:Sepsis / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D012772:Shock, Septic / Q000209:etiology / Q000276:immunology / Q000628:therapy; D051197:Toll-Like Receptor 4 / Q000502:physiology; D051193:Toll-Like Receptors / Q000502:physiology
D024243:HMGB1 Protein; D011486:Protein C; D011994:Recombinant Proteins; C495345:TLR4 protein, human; D051197:Toll-Like Receptor 4; D051193:Toll-Like Receptors